Daniel Rhee, M.D., M.P.H., pediatric surgeon and surgical director of the Pediatric Surgical Oncology Program at Johns Hopkins Children’s Center, discusses neuroblastoma, a complex cancer that requires a multidisciplinary treatment team. Neuroblastoma is rare, with only 700–800 new cases diagnosed in the U.S. per year, but it is the most common solid tumor seen in children. Dr. Rhee and his team are experienced clinicians dedicated to each child’s individual treatment plan.
Click here to more about the pediatric surgical oncology program.
Director, Pediatric Surgical Oncology Program
EXPERTISE Chest Wall Tumors, General Surgery, Germ Cell Tumors, Kidney Tumors, Minimally Invasive Surgery, Neonatal Congenital Anomalies, Neonatal Surgery, Neuroblastoma, Pancreatic Auto Islet Transplant, Pancreatitis Surgery, Pectus ...